Class II
Ongoing
Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01
Why: Failed Dissolution Specifications
- Company
- Eugia US LLC
East Windsor, NJ, United States - Reported
- Mar 13, 2024
- Recall started
- Feb 20, 2024
- Where sold
- OH, TN, LA, MS
- Amount
- 10,080 vials
- Full product description
- Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01
- Lots / codes affected
- Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.